Barings’s Core Scientific CORZ Stock Holding History

Barings’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,314,905	Closed	-$36.5M	–	157
2024 Q1	$36.5M	Buy	+10,314,905	New	+$35.8M	0.92%	16

Other funds holding CORZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

PCM

Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

CHP

Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Barings's CORZ Position: Q2 2024 in Review

Barings sold out of Core Scientific (CORZ) in Q2 2024, closing a stake of 10,314,905 shares — an estimated $36.5M sold.

Barings first reported a position in CORZ in Q1 2024 and held it in 1 quarter. The position peaked at $36.5M in Q1 2024. 189 funds tracked by Wall St. Rank hold CORZ as of Q2 2024.

Barings reported no remaining Core Scientific position as of Q2 2024 after selling out during the quarter.
Barings sold 10,314,905 Core Scientific shares in Q2 2024, an estimated $36.5M.
Barings first reported a position in Core Scientific in Q1 2024 and held it in 1 quarter.
Barings's Core Scientific position peaked at $36.5M in Q1 2024.
189 funds tracked by Wall St. Rank held Core Scientific as of Q2 2024.

Based on Barings's 13F filing for Q2 2024, filed 8 Aug 2024.